Wisconsin Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Buy
4,245
+3
+0.1% +$3.06K 2.42% 14
2026
Q1
$3.9M Sell
4,242
-982
-19% -$996K 2.14% 18
2025
Q4
$5.61M Buy
5,224
+147
+3% +$141K 2.84% 13
2025
Q3
$3.87M Sell
5,077
-2,018
-28% -$1.5M 1.98% 17
2025
Q2
$5.53M Buy
7,095
+53
+0.8% +$41.2K 3.05% 12
2025
Q1
$5.82M Sell
7,042
-333
-5% -$277K 3.71% 11
2024
Q4
$5.69M Sell
7,375
-64
-0.9% -$53K 3.13% 11
2024
Q3
$6.59M Buy
7,439
+42
+0.6% +$37.8K 3.46% 10
2024
Q2
$6.7M Buy
7,397
+76
+1% +$60.8K 3.39% 9
2024
Q1
$5.7M Buy
7,321
+55
+0.8% +$39.1K 2.99% 9
2023
Q4
$4.24M Buy
7,266
+2,477
+52% +$1.45M 2.52% 20
2023
Q3
$2.57M Buy
+4,789
New +$2.47M 1.7% 26

Other funds holding LLY

Wisconsin Capital Management's LLY Position: Q2 2026 in Review

Wisconsin Capital Management increased its Eli Lilly (LLY) stake by 0.07% in Q2 2026, buying an estimated $3.06K and bringing the position to 4,245 shares worth $5.09M. The position accounts for 2.42% of the portfolio, ranked #14.

Wisconsin Capital Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.7M in Q2 2024. 1,716 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wisconsin Capital Management held 4,245 shares of Eli Lilly worth $5.09M as of Q2 2026.
  • Wisconsin Capital Management bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 2.42% of Wisconsin Capital Management's portfolio in Q2 2026, its #14 holding.
  • Wisconsin Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Wisconsin Capital Management's Eli Lilly position peaked at $6.7M in Q2 2024.
  • 1,716 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wisconsin Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.